Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The impact of expiratory muscle strength training on voluntary cough effectiveness in Huntington's disease

R. Konvalinkova, M. Srp, K. Doleckova, V. Capek, O. Gal, M. Hoskovcova, R. Kliment, J. Muzik, E. Ruzicka, J. Klempir

. 2024 ; 31 (12) : e16500. [pub] 20240930

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25003241

Grantová podpora
MH CZ - DRO - VFN00064165 Všeobecná Fakultní Nemocnice v Praze

BACKGROUND AND PURPOSE: Dysfunction of the airway defence system in Huntington's disease (HD) is a significant but often overlooked problem. Although expiratory muscle strength training (EMST) is frequently utilized in cough effectiveness treatment, its specific impact in HD patients has not yet been explored. This study investigated the effects of EMST on voluntary peak cough flow (vPCF) in HD patients and evaluated the retention of potential gains post-intervention. METHODS: In this prospective case-controlled trial, 29 HD patients completed an 8-week wait-to-start period, which served to identify the natural development of expiratory muscle strength and vPCF. This was followed by 8 weeks of EMST training and an additional 8 weeks of follow-up. The study's outcome parameters, vPCF and maximum expiratory pressure (MEP), were measured against those of age- and sex-matched healthy controls. RESULTS: Huntington's disease patients had significantly lower MEP (p < 0.001) and vPCF (p = 0.012) compared to healthy controls at baseline. Following the EMST, significant improvements in MEP (d = 1.39, p < 0.001) and vPCF (d = 0.77, p = 0.001) were observed, with HD patients reaching the cough performance levels of healthy subjects. However, these gains diminished during the follow-up, with a significant decline in vPCF (d = -0.451, p = 0.03) and in MEP (d = -0.71; p = 0.002). CONCLUSIONS: Expiratory muscle strength training improves expiratory muscle strength and voluntary cough effectiveness in HD patients, but an ongoing maintenance programme is necessary to sustain the improvements.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003241
003      
CZ-PrNML
005      
20250206104206.0
007      
ta
008      
250121s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/ene.16500 $2 doi
035    __
$a (PubMed)39344651
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Konvalinkova, Romana $u Department of Neurology and Centre of Clinical Neuroscience, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
245    14
$a The impact of expiratory muscle strength training on voluntary cough effectiveness in Huntington's disease / $c R. Konvalinkova, M. Srp, K. Doleckova, V. Capek, O. Gal, M. Hoskovcova, R. Kliment, J. Muzik, E. Ruzicka, J. Klempir
520    9_
$a BACKGROUND AND PURPOSE: Dysfunction of the airway defence system in Huntington's disease (HD) is a significant but often overlooked problem. Although expiratory muscle strength training (EMST) is frequently utilized in cough effectiveness treatment, its specific impact in HD patients has not yet been explored. This study investigated the effects of EMST on voluntary peak cough flow (vPCF) in HD patients and evaluated the retention of potential gains post-intervention. METHODS: In this prospective case-controlled trial, 29 HD patients completed an 8-week wait-to-start period, which served to identify the natural development of expiratory muscle strength and vPCF. This was followed by 8 weeks of EMST training and an additional 8 weeks of follow-up. The study's outcome parameters, vPCF and maximum expiratory pressure (MEP), were measured against those of age- and sex-matched healthy controls. RESULTS: Huntington's disease patients had significantly lower MEP (p < 0.001) and vPCF (p = 0.012) compared to healthy controls at baseline. Following the EMST, significant improvements in MEP (d = 1.39, p < 0.001) and vPCF (d = 0.77, p = 0.001) were observed, with HD patients reaching the cough performance levels of healthy subjects. However, these gains diminished during the follow-up, with a significant decline in vPCF (d = -0.451, p = 0.03) and in MEP (d = -0.71; p = 0.002). CONCLUSIONS: Expiratory muscle strength training improves expiratory muscle strength and voluntary cough effectiveness in HD patients, but an ongoing maintenance programme is necessary to sustain the improvements.
650    _2
$a lidé $7 D006801
650    12
$a Huntingtonova nemoc $x patofyziologie $x komplikace $x rehabilitace $7 D006816
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé středního věku $7 D008875
650    _2
$a dospělí $7 D000328
650    12
$a kašel $x patofyziologie $x etiologie $7 D003371
650    12
$a svalová síla $x fyziologie $7 D053580
650    12
$a dýchací svaly $x patofyziologie $7 D012132
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a prospektivní studie $7 D011446
650    _2
$a dechová cvičení $x metody $7 D001945
650    _2
$a výsledek terapie $7 D016896
650    _2
$a odporový trénink $x metody $7 D055070
655    _2
$a časopisecké články $7 D016428
700    1_
$a Srp, Martin $u Department of Neurology and Centre of Clinical Neuroscience, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000322150272
700    1_
$a Doleckova, Kristyna $u Department of Neurology and Centre of Clinical Neuroscience, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Capek, Vaclav $u Department of Neurology and Centre of Clinical Neuroscience, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Gal, Ota $u Department of Neurology and Centre of Clinical Neuroscience, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Hoskovcova, Martina $u Department of Neurology and Centre of Clinical Neuroscience, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Kliment, Radim $u Faculty of Biomedical Engineering, Czech Technical University, Prague, Czech Republic
700    1_
$a Muzik, Jan $u Faculty of Biomedical Engineering, Czech Technical University, Prague, Czech Republic
700    1_
$a Ruzicka, Evzen $u Department of Neurology and Centre of Clinical Neuroscience, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Klempir, Jiri $u Department of Neurology and Centre of Clinical Neuroscience, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
773    0_
$w MED00001629 $t European journal of neurology $x 1468-1331 $g Roč. 31, č. 12 (2024), s. e16500
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39344651 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104201 $b ABA008
999    __
$a ok $b bmc $g 2263159 $s 1239248
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 31 $c 12 $d e16500 $e 20240930 $i 1468-1331 $m European journal of neurology $n Eur J Neurol $x MED00001629
GRA    __
$a MH CZ - DRO - VFN00064165 $p Všeobecná Fakultní Nemocnice v Praze
LZP    __
$a Pubmed-20250121

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...